Private company

Applied Therapeutics, Inc.

Last updated Oct 16, 2026.

Overview

  • IndustryPharmaceutical Preparations
  • HeadquartersDE
  • Incorporated inDE2
  • Business address545 Fifth Avenue, Suite 1400, New York, Ny 100172
  • Filer categoryNon-accelerated filer, Smaller reporting company2

Financials

From the company’s reports to the SEC. Every number links to the filing it came from.

Key numbers, fiscal 2024

-22922.9%Operating margin3
-23214.1%Net margin3
-95.4%Revenue growth, 20243
-185.3%Return on equity3

Where the money goes

Where each dollar of revenue went, fiscal 2024

  • Research and development100¢$48.7M

Out of $455.0K in revenue.3 The company lost money this year.

Financial statements

Revenue3$455.0K in 2024−95% since 2023
0$2.5M$5.0M$7.5M$10.0M2023: $10.0M$10.0M20232024: $455.0K$455.0K2024−95%
Operating income456783-$104.3M in 2024+672% since 2018
-$150.0M-$100.0M-$50.0M02018: -$13.5M-$13.5M20182019: -$45.6M-$45.6M2019+237%2020: -$94.5M-$94.5M2020+107%2021: -$105.6M-$105.6M2021+12%2022: -$83.0M-$83.0M2022−21%2023: -$64.5M-$64.5M2023−22%2024: -$104.3M-$104.3M2024+62%
Net income456783-$105.6M in 2024+539% since 2018
-$150.0M-$100.0M-$50.0M02018: -$16.5M-$16.5M20182019: -$45.5M-$45.5M2019+175%2020: -$94.0M-$94.0M2020+106%2021: -$105.6M-$105.6M2021+12%2022: -$82.5M-$82.5M2022−22%2023: -$119.8M-$119.8M2023+45%2024: -$105.6M-$105.6M2024−12%
Fiscal year2018201920202021202220232024
Revenue$10.0M3$455.0K3
Research and development$11.5M4$32.4M5$61.8M6$62.6M7$55.6M8$53.9M3$48.7M3
Operating income-$13.5M4-$45.6M5-$94.5M6-$105.6M7-$83.0M8-$64.5M3-$104.3M3
Net income-$16.5M4-$45.5M5-$94.0M6-$105.6M7-$82.5M8-$119.8M3-$105.6M3
Earnings per share-$4.286-$4.127-$2.188-$1.423-$0.763
Earnings per share (diluted)-$4.286-$4.127-$2.188-$1.423-$0.763

Compare Applied Therapeutics, Inc. with another company

Former names

  • Applied Therapeutics Inc.Feb 8, 2017 to Mar 11, 20242

Recent filings

  1. Feb 4, 20264
  2. Feb 3, 20268-K
  3. Feb 3, 20264
  4. Feb 3, 20264
  5. Feb 3, 20264
  6. Feb 3, 20264
  7. Feb 3, 20264
  8. Feb 3, 20264
  9. Jan 2, 20264
  10. Dec 18, 20254
  11. Dec 12, 20258-K
  12. Nov 20, 20258-K
  13. Nov 13, 20258-K
  14. Nov 13, 202510-Q
  15. Oct 1, 20254

Every filing from the last three years, summarized. The full record is on SEC EDGAR.1